Inactive Instrument

Analyst Reco. Galena Biopharma Inc Nasdaq

Equities

Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences Group to $6 From $10, Keeps Overweight Rating	22-06-28	MT
Alliance Global Adjusts Price Target on SELLAS Life Sciences Group to $14 From $16.50, Reiterates Buy Rating	22-04-08	MT
Ladenburg Thalmann Starts SELLAS Life Sciences Group at Buy with $15 Price Target	22-02-07	MT
Maxim Group Adjusts SELLAS Life Sciences Group Price Target to $12 From $21, Maintains Buy Rating	22-02-02	MT
Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences to $16 From $18, Reiterates Overweight Rating	21-12-03	MT
SELLAS LIFE SCIENCES : Cantor Fitzgerald Starts SELLAS Life Sciences Group at Overweight With $18 Price Target	21-07-21	MT
SELLAS LIFE SCIENCES : Maxim Adjusts Price Target on SELLAS Life Sciences Group to $21 From $12, Keeps Buy Rating	21-06-25	MT

No results for this search